{"nct_id":"NCT02511184","title":"Crizotinib Plus Pembrolizumab In Alk-Positive Advanced Non Small Cell Lung Cancer Patients","status":"TERMINATED","status_verified_date":"2019-04","start_date":"2015-10","start_date_type":"ACTUAL","primary_completion_date":"2017-12","primary_completion_date_type":"ACTUAL","completion_date":"2017-12","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["PFE"]}